Mitochondrial D310 instability in Asian Indian breast cancer patients

Tumor Biology

Volumn 34, Issue 4, 2013, Pages 2427-2432

  Alhomidi, Mohammed A ^a,b   Vedicherla, Bhavani ^a   Movva, Sireesha ^c   Rao, Prabhakar K ^b   Ahuja, Yog R ^c   Hasan, Qurratulain ^a,c,d  

^a Bhagavan Mahavir Medical and Research Centre   (India)

^b OSMANIA UNIVERSITY   (India)

^c Vasavi Medical and Research Centre   (India)

^d KAMINENI HOSPITALS   (India)

Author keywords

Asian Indians; Breast cancer; D310; Mitochondrial control region; PCT

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DISEASE COURSE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENOMIC INSTABILITY; HETEROPLASMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDIAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 84881476584     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0793-0     Document Type: Article

References (32)

1. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Childhood. 2004;4:5.
2. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin D. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC Cancer Base No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer. 2010;2285-92.
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
4. Levi F, Lucchini F, Negri E, La Vecchia C. Continuing declines in cancer mortality in the European Union. Ann Oncol. 2007;18(3):593.
5. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Ann Rev Public health. 1996;17(1):47-67.
6. Dey S, Boffetta P, Mathews A, Brennan P, Soliman A, Mathew A. Risk factors according to estrogen receptor status of breast cancer patients in Trivandrum, South India. Int J Cancer. 2009;125(7):1663-70.
7. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst. 1993;85(22):1819.
8. Wang C, Youle RJ. The role of mitochondria in apoptosis. Annu Rev Genet. 2009;43:95-118.
9. Anderson S, Bankier A, Barrell BG, De Bruijn M, Coulson A, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457-65.
10. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2(1):67-71.
11. Ye C, Shu XO, Pierce L, Wen W, Courtney R, Gao YT, et al. Mutations in the mitochondrial DNA D-loop region and breast cancer risk. Breast Cancer Res Treat. 2010;119(2):431-6.
12. Morselli E, Galluzzi L, Kepp O, Vicencio JM, Criollo A, Maiuri MC. Anti-and pro-tumor functions of autophagy. Biochim Biophys Acta. 2009;1793(9):1524-32.
13. Warburg. On the origin of cancer cells. Science. 1956;123(3191):6.
14. Bianchi NO, Bianchi MS, Richard SM. Mitochondrial genome instability in human cancers. Mutat Res Rev Mutat Res. 2001;488(1):9-23.
15. Modica-Napolitano JS, Kulawiec M, Singh KK. Mitochondria and human cancer. Curr Mol Med. 2007;7(1):121-31.
16. Lee HC, Yin PH, Lin JINC, Wu CC, Chen CYI, Wu CWUN, et al. Mitochondrial genome instability and mtDNA depletion in human cancers. Ann N Y Acad Sci. 2005;1042(1):109-22.
17. Suzuki M, Toyooka S, Miyajima K, Iizasa T, Fujisawa T, Bekele NB, et al. Alterations in the mitochondrial displacement loop in lung cancers. Clin Cancer Res. 2003;9(15):5636.
18. Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001;61(19):7015.
19. Vasavi M, Ponnala S, Gujjari K, Boddu P, Bharatula RS, Prasad R, et al. DNA methylation in esophageal diseases including cancer: special reference to hMLH1 gene promoter status. Tumori. 2006;92(2):155.
20. Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80-3.
21. Modica-Napolitano JS, Singh K. Mitochondria as targets for detection and treatment of cancer. Expert Rev Mol Med. 2002;2(1):1-19.
22. Lee HC, Wei YH. Mitochondrial DNA instability and metabolic shift in human cancers. Int J Mol Sci. 2009;10(2):674-701.
23. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 2001;61(20):7623.
24. Tan DJ, Bai RK, Wong LJC. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002;62(4):972-6.
25. Lu J, Sharma LK, Bai Y. Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res. 2009;19(7):802-15.
26. Richard SM, Bailliet G, Páez GL, Bianchi MS, Peltomäki P, Bianchi NO. Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. 2000;60(15):4231.
27. Dakubo GD. Mitochondrial genetics and cancer. Berlin: Springer; 2010.
28. Salas A, Yao YG, Macaulay V, Vega A, Carracedo Á, Bandelt HJ. A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. 2005;2(11):e296.
29. Mithani SK, Taube JM, Zhou S, Smith IM, Koch WM, Westra WH, et al. Mitochondrial mutations are a late event in the progression of head and neck squamous cell cancer. Clin Cancer Res. 2007;13(15):4331.
30. Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science. 2008;320(5876):661.
31. Lièvre A, Chapusot C, Bouvier AM, Zinzindohoué F, Piard F, Roignot P, et al. Clinical value of mitochondrial mutations in colorectal cancer. J Clin Oncol. 2005;23(15):3517-25.
32. Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet Cytogenet. 2008;181(1):16-9.